The new species, named Coenaletes colombianus, belongs to a family of springtails known as Coenaletidae, a group of minute six-legged arthropods more closely studied by specialists than by the general public. Springtails, or Collembola, are among the most abundant microarthropods on the planet, thriving in soils, leaf litter, and even on the surfaces of glaciers. But the Coenaletidae are unusual in a very specific way: they are obligate commensals, meaning they live exclusively in association with terrestrial hermit crabs of the genus Coenobita. Only two species of this family had ever been described before, one from New Guinea and one from the Caribbean. The Colombian discovery marks the third known species in the entire genus, and the first from the Pacific coast of the Americas.

The expedition that led to the discovery took researchers to the shores of Nuquí, in the Chocó department of Colombia, a region famous for its dense rainforest meeting the ocean. There, they collected hermit crabs of the species Coenobita compressus, easily recognized by their elongated eyestalks and their habit of occupying empty snail shells, in this case shells of the marine snail Tegula atra. To coax the springtails off their hosts, the researchers placed the crabs in plastic containers filled with fresh water. The technique worked: the springtails and their molted exoskeletons detached and floated to the surface, where they could be collected with fine tools. The specimens were then fixed in 96% ethanol and prepared for detailed morphological study.

Back in the laboratory, the specimens underwent a rigorous preparation process. They were cleared with potassium hydroxide and lactic acid to render their tiny bodies transparent, then mounted on slides in Hoyer’s solution, a medium that hardens over a week of drying at 45 to 50 degrees Celsius. Once prepared, the slides were examined and photographed with a Carl Zeiss Primo Star phase-contrast microscope, allowing researchers to document every seta, spine, and sensory organ. Additional images were captured with a LEICA M205A stereomicroscope equipped with an auto-mounting system, and with a HITACHI TM4000Plus II environmental scanning electron microscope, which revealed surface details at extraordinary magnification. For SEM imaging, specimens were transferred from ethanol to amyl acetate for five hours to maintain turgor and prevent body collapse within the vacuum chamber, then air-dried and affixed to cardboard micropoints with polyvinyl acetate adhesive.

The morphological analysis revealed a suite of characters that distinguish Coenaletes colombianus from its two known relatives. Adult males measure 1.56 millimeters in body length and females 1.61 millimeters, with a depressed body form and a head that is wider than long. The antennae consist of four segments, and males bear a distinctive pattern of spines: one on the first antennal segment, two on the second, and three on the third. This 1, 2, 3 arrangement matches that of the New Guinea species, Coenaletes vangoethemi, but differs from the Caribbean species, Coenaletes caribaeus, which shows a 2, 2, 2 pattern. The lateral spines on the trunk, however, follow a 4, 1, 1, 1 arrangement on the third thoracic and first three abdominal segments, matching the Caribbean species rather than the New Guinea one. The combination of these characters, along with differences in the number of setae on the dens, the width-to-length ratio of the second antennal segment, and the length of the mucrodens, confirmed the Colombian population as a species in its own right.

One of the most remarkable aspects of the study is the detailed documentation of the species’ ontogenetic development, from the first instar to adulthood. The researchers measured specimens at each postembryonic stage, recording body length, head dimensions, antennal segment lengths, and the dimensions of the fused third and fourth abdominal segments. First instar juveniles measure just 907 micrometers in body length, growing to over 1.5 millimeters in adults. The ventral setation, in particular, shows a gradual and predictable increase in setae number across development, with the corpus tenaculi, the third thoracic sternum, the ventral second abdominal segment, the coxa furcalis, and the postlabial setae undergoing the most significant changes. This developmental series provides a reference framework that was previously unavailable for the genus, as earlier descriptions of the two known species omitted many of these ventral characters entirely.

The species’ morphology reflects its highly specialized lifestyle. The mandible bears a well-developed molar plate but lacks apical teeth, and the maxilla is small with six subequal lamellae. The pronotum is reduced, and the third and fourth abdominal segments are fused dorsally and laterally but not ventrally, creating an elongated trunk region. Males possess spines on the antennae and on lateral tubercles of the third thoracic and third abdominal segments, and the dorsal apex of the tibiotarsus is excavated at the base of the claw. The claw itself bears enlarged lateral teeth and is capable of folding, an adaptation that may aid in gripping the host crab’s surface. The furcula, the springtail’s characteristic jumping organ, is well developed but does not reach the ventral tube, and the mucro is falcate and fused to the dens.

During the study, the researchers encountered a teratological specimen, an individual with abnormal development that lacked setae laterally on the first three abdominal segments and showed a deformed abdomen. On the left side of the fused third and fourth abdominal segments, most ordinary setae, all macrosetae, both bothriotricha, the microsensillum, and most mesosetae were absent. Such asymmetries and abnormalities, while rare, provide insight into the developmental plasticity of the species and the challenges of documenting chaetotaxy in a group with hypertrichosis, where the dorsal setal pattern is too dense to check reliably during development.

The discovery of Coenaletes colombianus raises compelling questions about the biogeography of this enigmatic genus. With one species on New Guinea, one in the Caribbean, and now one on the Pacific coast of Colombia, the genus appears to have a remarkably disjunct distribution across tropical oceans. The obligate association with terrestrial hermit crabs suggests that the evolutionary history of the springtails is intertwined with that of their hosts, which themselves colonized land from marine ancestors. The Chocó region, with its extraordinary endemism and its position at the crossroads of the Neotropics, may harbor additional undiscovered commensal species, and the researchers suggest that further surveys of hermit crabs along tropical coastlines could reveal more surprises.

The new species is described and illustrated in the journal ZooKeys, with a key provided for the identification of all three species known in the genus. The type material, including the holotype male and numerous paratypes, is deposited at the Facultad de Ciencias of the Universidad Nacional Autónoma de México and at the Entomological collection of the Museo entomológico UNAB of the Universidad Nacional de Colombia in Bogotá. The specific epithet colombianus is a geographical adjective honoring the country where the type material was collected. As researchers continue to explore the microarthropod fauna associated with hermit crabs, each new discovery underscores the extraordinary specificity of commensal relationships and the remarkable diversity that persists in the hidden corners of the natural world.

Subject of Research: Taxonomic description of a new obligate commensal springtail species associated with terrestrial hermit crabs in Colombia.

Article Title: One new obligate commensal species of Coenaletes ( Collembola , Coenaletidae ) from the hermit crab Coenobita compressus ( Crustacea , Coenobitidae ) from Colombia

Article References: Arango, A., Ojeda, M., Serna, F., & Palacios-Vargas, J. G. (2026). One new obligate commensal species of Coenaletes (Collembola, Coenaletidae) from the hermit crab Coenobita compressus (Crustacea, Coenobitidae) from Colombia. ZooKeys, 1293, 79-94. https://doi.org/10.3897/zookeys.1293.206618

Image Credits: AI Generated

DOI: 10.3897/zookeys.1293.206618

Keywords: Collembola, springtails, hermit crabs, commensalism, new species, Colombia, ZooKeys, taxonomy, Coenaletidae, biodiversity, obligate, commensal

The central discovery concerns fucosylation, the attachment of fucose sugars to mucin 2, or MUC2, the gel-forming glycoprotein that constitutes the bulk of the colonic mucus layer. Fucose residues added to MUC2 are not cosmetic. They alter the mucus matrix in ways that support its integrity and its interactions with the microbial community. In colitis, this fucosylation is lost, and the mucus barrier weakens, leaving the epithelial surface exposed. The new study shows that the flagellin of L. 3–1-57, the protein that forms the propeller-like appendage of the bacterium, can reverse this deficit through a defined immunological cascade.

The clinical foundation of the work rests on two cohorts of human participants. Compared with healthy controls and with patients whose ulcerative colitis was in remission, patients with active disease showed reduced abundance of L. 3–1-57 in their gut microbiota. The depletion was not random. The lower the abundance of the bacterium, the more severe the disease, an inverse correlation that held across the study population. This pattern suggests that L. 3–1-57 is not merely a passive bystander in colitis but a component of the microbial community whose presence tracks with mucosal health.

To test whether the relationship is causal, the team turned to mouse models of chemically induced colitis. Oral administration of live L. 3–1-57 attenuated intestinal inflammation and mucus barrier dysfunction. Purified flagellin from the bacterium, delivered without the living organism, achieved the same protection. The contrast with a well-known gut pathobiont was stark: flagellin from Escherichia coli exacerbated disease rather than relieving it. This strain-specific divergence is one of the most technically significant aspects of the study, because flagellins from different bacteria are structurally similar yet immunologically distinct, and the field has lacked a clear account of which commensal flagellins promote homeostasis rather than inflammation.

The mechanistic chain begins at Toll-like receptor 5, or TLR5, the innate immune receptor that recognizes bacterial flagellin. Using binding assays, the researchers demonstrated that L. 3–1-57 flagellin binds TLR5 with high affinity. Upon this engagement, dendritic cells, the antigen-presenting sentinels of the mucosal immune system, are activated to produce interleukin-23. Interleukin-23 in turn expands the population of group 3 innate lymphoid cells, or ILC3s, that produce interleukin-22. Interleukin-22 is a cytokine with well-documented effects on epithelial cells, and in this context it drives the expression of fucosyltransferase 2, the enzyme that catalyzes the α-1,2-linked fucosylation of MUC2. The restored fucosylation rebuilds the mucus matrix and closes the protective loop.

The team then dismantled the pathway piece by piece to confirm that each element is indispensable. Genetic ablation of Tlr5 in mice abolished the protective effect of the flagellin. Pharmacological inhibition of α-1,2-fucosylation eliminated the benefit even when the immune cascade was intact. Neutralization of interleukin-22 likewise erased the protection. These loss-of-function experiments establish that the TLR5–IL-23–IL-22 axis and the fucosylation it drives are not merely correlated with recovery but are required for it, a standard of mechanistic proof that many microbiome studies do not reach.

A further technical point addresses a common concern about flagellin-based therapies. Analysis of the gut microbiota by 16S rRNA amplicon sequencing showed that orally administered L. 3–1-57 flagellin did not induce broad restructuring of the microbial community. The protection, in other words, is not mediated by wholesale alteration of the microbiome but by a targeted immune and glycosylation pathway. Detection of His-tagged flagellin in colonic mucus confirmed that the protein reaches its site of action after oral delivery, and flow cytometric analysis documented the activation of dendritic cells in the colonic lamina propria and mesenteric lymph nodes.

The translational implications are threefold. First, the authors nominate L. 3–1-57 as a candidate next-generation probiotic, a living organism whose administration could restore a depleted protective community member. Second, the flagellin itself is proposed as a postbiotic therapy, a purified microbial product that delivers the benefit without the need for live bacteria, an approach that may offer more predictable dosing and safety. Third, the fecal depletion of L. 3–1-57 is suggested as a noninvasive auxiliary diagnostic biomarker, a measurable microbial signal that could complement clinical assessment of disease activity.

The study also contributes to a broader reevaluation of flagellin, a molecule long viewed with suspicion because of its role in inflammatory signaling. The new work demonstrates that flagellin is not a monolithic inflammatory trigger but a family of strain-specific immunomodulators whose effects depend on the producing organism. Flagellins from commensal bacteria are among the most potent modulators of intestinal immunity, yet their homeostatic functions have remained poorly defined. By identifying a commensal flagellin that promotes mucosal repair through a defined receptor-to-glycosylation pathway, the study provides a framework for distinguishing protective from harmful flagellins and for exploiting the protective ones therapeutically.

The work was supported by the National Natural Science Foundation of China and related funding programs, and was approved by the Ethics Committee of Tianjin Medical University General Hospital and the Tianjin Medical University Animal Care and Use Committee. The article is open access under a Creative Commons license, and the authors declare no competing interests. As with all preclinical microbiome research, the findings in mouse models and human associations will require further validation before clinical application, but the study establishes a complete mechanistic account of how a single commensal bacterium, acting through its flagellin and a defined immune axis, can rebuild the chemical architecture of the mucus barrier that colitis destroys.

,

Subject of Research: Commensal Lachnospiraceae bacterium mitigates colitis-induced mucin fucosylation deficits through ILC3/IL-22 axis

Article Title: Commensal Lachnospiraceae bacterium mitigates colitis-induced mucin fucosylation deficits through ILC3/IL-22 axis

Article References: Li, L., Jiang, J., Huang, Y., Yang, S., Wei, J., Dong, W., Zhong, W., Wang, B., Su, X., Cao, H., & Liu, T. (2026). Commensal Lachnospiraceae bacterium mitigates colitis-induced mucin fucosylation deficits through ILC3/IL-22 axis. Genome Biology. https://doi.org/10.1186/s13059-026-04304-7

Image Credits: AI Generated

DOI: 10.1186/s13059-026-04304-7

Keywords: Commensal, Lachnospiraceae, bacterium, mitigates, colitis-induced, mucin, fucosylation, deficits, ILC3, IL-22, axis, scientific research

The finding lands at the intersection of two of the most rapidly evolving fields in cancer biology: the tumor microbiome and the study of fungi as overlooked members of our resident microbial communities. For decades, research into the microbiome concentrated overwhelmingly on bacteria, and rightly so, given their staggering abundance. But fungi, though numerically minor, possess qualities that make them uniquely capable of influencing their hosts. They have robust cell walls built from beta-glucans and other sugar polymers, they can switch between morphological forms, and they are armed with molecules that interact directly with the innate immune system. In recent years, fungal DNA and even intact fungal cells have been detected inside tumors ranging from pancreatic cancer to melanoma, prompting an urgent question: are these organisms contaminants, opportunists exploiting a weakened tissue, or drivers of malignant progression?

The new study, led by Lai and colleagues, adds substantial weight to the third possibility, at least in the context of advanced prostate cancer. By analyzing fecal samples and tumor tissue from patients with castration-resistant prostate cancer, the team found that Nakaseomyces glabratus was enriched in both compartments relative to comparisons, indicating that the fungus is not only more abundant in the gut of these patients but also physically present within the tumor microenvironment itself. That dual enrichment is important. A microbe found solely in stool could simply reflect a systemic shift in body ecology; a microbe found inside the tumor, in the same patients, raises the possibility of migration — that organisms originating in the intestinal lumen can translocate across epithelial barriers, travel through circulation or adjacent tissues, and colonize tumor sites.

Nakaseomyces glabratus, known in older literature as Candida glabrata, is no exotic pathogen. It is a genuine commensal, carried harmlessly by a large fraction of healthy people on mucosal surfaces of the gut, the genitourinary tract, and elsewhere. In immunocompromised individuals, however, it can become an opportunistic pathogen and is a recognized cause of invasive candidiasis in hospital settings. Its evolutionary kinship with Candida albicans makes the new findings particularly thought-provoking, because C. albicans has already been implicated in other contexts in which commensal fungi appear to reshape host physiology, from inflammatory bowel disease to oral carcinogenesis. The new work extends this emerging paradigm to the prostate, an organ whose tumor microenvironment had not previously been considered a destination for migrating fungi.

The castrated mouse experiments provide the study’s most consequential evidence. Prostate cancers typically depend on androgen receptor signaling, which is why androgen deprivation therapy — surgical or chemical castration — is a mainstay of treatment for advanced disease. Over time, however, tumors adapt and progress despite near-castrate hormone levels, becoming the castration-resistant form that accounts for most prostate cancer deaths. When the researchers gave Nakaseomyces glabratus to castrated mice bearing prostate tumors, the fungus accelerated cancer progression in this precisely defined hormonal context. In other words, the organism’s pro-tumor effect was observed under the very conditions that define the lethal, treatment-resistant stage of human disease, closely mirroring the patient population in which the fungus was found to be enriched.

How might a commensal yeast push a tumor toward faster growth? The authors’ demonstration does not yet fully resolve the mechanism, but the broader literature offers several plausible avenues. Fungal cell wall components, including beta-glucans and mannans, are recognized by innate immune receptors such as Dectin-1 and Toll-like receptors, which can trigger inflammatory programs that tumors frequently exploit for growth, survival, and immune evasion. Chronic low-grade inflammation within the tumor microenvironment can promote angiogenesis, remodel the extracellular matrix, and suppress effective anti-tumor immunity, all of which favor progression. Fungi can also alter the local metabolic landscape, consume nutrients, and engage in cross-kingdom interactions with bacteria that themselves modulate inflammation and therapy response. Disentangling which of these pathways Nakaseomyces glabratus activates in the prostate will be a central task for follow-up research.

The translocation question is equally compelling. The intestinal barrier is a heavily policed boundary, and yet a growing body of work shows that microbial migration from gut to distant tissues is far more common than once believed. Bacterial species have been traced from the gut lumen into pancreatic tumors, breast tumors, and lymph nodes, sometimes with measurable functional consequences for disease course. The new study suggests fungi can join this list. If Nakaseomyces glabratus indeed migrates from the gut into prostate tumors, the clinical implications are immediately apparent: the gut mycobiome becomes a potential modifiable risk factor, and strategies to reduce fungal load, alter fungal community composition, or block fungal recognition pathways could, in principle, slow disease progression in affected patients.

Caution is, as always in this field, warranted. Enrichment and acceleration in mice establish association and a causal effect in an animal model, but they do not by themselves prove that the fungus drives progression in every patient, nor that eradicating it would improve outcomes in humans. Tumor-associated microbes can be difficult to distinguish from contaminants, and the field has grappled with reproducibility concerns surrounding low-biomass microbiome sequencing. Moreover, host factors — immune status, diet, prior antifungal or antibiotic exposure, and disease stage — likely shape whether a commensal yeast remains benign or becomes pro-tumorigenic. The most rigorous next steps will include longitudinal studies tracking fungal burden as disease progresses, mechanistic dissection of the immune signaling involved, and intervention experiments in models that test whether reducing the fungus reverses the accelerated growth.

Nevertheless, the conceptual shift is hard to overstate. Prostate cancer research has concentrated on hormones, genetics, and immune checkpoints; the possibility that a common commensal fungus physically resides inside prostate tumors and shapes their trajectory adds an entirely new layer to the disease model. It also resonates with an expanding appreciation that the human body is a multi-kingdom ecosystem, in which fungi, bacteria, viruses, and host cells engage in a continuous negotiation whose outcome can be health or disease. If further work confirms and extends these findings, mycobiome profiling could one day sit alongside PSA testing and genomic analysis in the clinical workup of advanced prostate cancer, and antifungal or microbiome-targeted interventions could emerge as adjuncts to existing therapies.

For now, the study stands as a vivid reminder that the microbes we carry with us every day are not always neutral companions. A yeast that spends most of its existence quietly metabolizing in our intestines can, under the right circumstances, find its way into a tumor and help it grow faster. Understanding when, how, and in whom that happens may open one of the most unexpected new fronts in the fight against castration-resistant prostate cancer — a front that begins not in the prostate at all, but in the gut.

Subject of Research: Enrichment of the commensal fungus Nakaseomyces glabratus in castration-resistant prostate cancer and its acceleration of tumor progression in mice

Article Title: Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression

Article References: Lai, P., Liu, L., Pernigoni, N., Du, Y., Braga, D., Troiani, M., Attanasio, G., Li, Y., Song, P., Pasquini, E., Rezzonico Jost, T., Huang, X., Maddalena, M., Mosole, S., Rinaldi, A., Pecoraro, G., Pedrani, M., Valdata, A., Bancaro, N., … Alimonti, A. (2026). Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression. Nature Cancer. https://doi.org/10.1038/s43018-026-01229-9

Image Credits: AI Generated

DOI: 10.1038/s43018-026-01229-9

Keywords: Nakaseomyces glabratus, prostate cancer, castration-resistant prostate cancer, tumor microbiome, mycobiome, fungal translocation, commensal fungi, tumor microenvironment, androgen deprivation, cancer progression, Nature Cancer, Commensal